Cel-Sci Corp (AMEX:CVM) (was HIV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)

CVM 6.660

+0.5%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Shutters who wrote (2194)	10/27/1998 4:04:00 PM
From: Tom Shutters	Read Replies (1) of 2836

"Expert Dispels AIDS Vaccine Myths" ..."Vaccines must prevent all disease. "Few vaccines prevent infection completely," said Clements-Mann. "Far from providing sterilizing immunity -- that is, the complete prevention of infection -- the goal for all vaccines of public health importance is to provide sufficient immunity to ameliorate disease."... ..."Multiple field trials are the rule for successful vaccine development, not the exception. Rather than focus on the idea of a single, ultimate trial, the expectation must be that multiple trials will be required, with each successive field trial being designed to address questions raised by the positive or negative findings in earlier trials."... "...If a vaccine trial fails to demonstrate efficacy, the development of effective vaccines is set back. "On the contrary," said Clements-Mann, "by finding out why a vaccine failed in efficacy trials, scientists and manufacturers can then modify it, and in subsequent trials demonstrate its ability to provide substantial protection to target populations."... newsalert.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next